Most Recent
The owners and operators of five Melbourne theatres have filed legal action against Ansvar Insurance seeking more than $20 million in business interruption cover for losses stemming from closures during the COVID-19 pandemic.
A defamation case brought by former footy show host Sam Newman and AFL veteran Donald Scott against sports photographer Wayne Ludbey over comments made about a historic image of indigenous AFL footballer Nicky Winmar has settled.
A judge has questioned whether he should allow prosecutors to amend charges against ANZ and its treasurer in a criminal cartel case over a $2.5 billion share placement after the bank argued the charges were defective and should be quashed.
Prefab concrete company Evolution Precast Systems failed to install reinforced concrete in Sydney's ill-fated Opal Tower and knew about a prior failure with one of the building's panels, engineer WSP Structures alleges in a cross-claim lobbed in a class action on behalf of residents of the tower.
Clive Palmer's Mineralogy has appealed a ruling tossing a lawsuit it brought against ASIC, which a judge called an "ill-disguised collateral attack" on the regulator for criminal proceedings against the billionaire mining magnate over $12 million in payments made to his political party in 2013.
A Federal Court judge has taken a swipe at new regulations that require class action funding arrangements to be registered as managed investment schemes, saying it was difficult to reconcile the new rules with the class action regime.
The NSW Police have commenced an investigation into Forum Finance and director Bill Papas, which have been accused by Westpac, French investment bank Societe Generale and Japanese bank SMBC of a $400 million fraud.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.
Software company DST Bluedoor is fighting to access communications between its former founding director and AMP in a $35.5 million legal stoush alleging the financial services firm induced 11 employees to jump ship after licensing its online platform.
Botox maker Allergan has successfully challenged a Federal Court judgment dismissing its trade mark lawsuit against an Australian company selling topical creams as an alternative to Botox injections.